Skip navigation
Universidade de Brasília
Use este identificador para citar ou linkar para este item: http://repositorio2.unb.br/jspui/handle/10482/44883
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_OverviewImmunogenicCell.pdf1,79 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorRodrigues, Mosar Corrêa-
dc.contributor.authorMorais, José Athayde Vasconcelos-
dc.contributor.authorGanassin, Rayane-
dc.contributor.authorOliveira, Giulia Rosa Tavares-
dc.contributor.authorCosta, Fabiana Chagas-
dc.contributor.authorMorais, Amanda Alencar Cabral-
dc.contributor.authorSilveira, Ariane Pandolfo-
dc.contributor.authorSilva, Victor Carlos Mello-
dc.contributor.authorLongo, João Paulo Figueiró-
dc.contributor.authorMuehlmann, Luis Alexandre-
dc.date.accessioned2022-09-23T21:37:33Z-
dc.date.available2022-09-23T21:37:33Z-
dc.date.issued2022-07-27-
dc.identifier.citationRODRIGUES, Mosar Corrêa et al. An overview on immunogenic cell death in cancer biology and therapy. Pharmaceutics, Basel, v. 14, n. 8, art. 1564, jul. 2022. DOI 10.3390/pharmaceutics14081564. Disponível em: https://www.mdpi.com/1999-4923/14/8/1564. Acesso em: 23 set. 2022.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/44883-
dc.language.isoInglêspt_BR
dc.publisherMDPIpt_BR
dc.rightsAcesso Abertopt_BR
dc.titleAn overview on immunogenic cell death in cancer biology and therapypt_BR
dc.typeArtigopt_BR
dc.subject.keywordMorte celular imunogênicapt_BR
dc.subject.keywordCâncer - tratamentopt_BR
dc.subject.keywordSistema imunológicopt_BR
dc.rights.licensePharmaceutics - Articles published in Sustainability will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2022 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). Fonte: https://www.mdpi.com/journal/pharmaceutics/about. Acesso em: 23 set. 2022.pt_BR
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics14081564pt_BR
dc.description.abstract1Immunogenic cell death (ICD) is a modality of regulated cell death that is sufficient to promote an adaptive immune response against antigens of the dying cell in an immunocompetent host. An important characteristic of ICD is the release and exposure of damage-associated molecular patterns, which are potent endogenous immune adjuvants. As the induction of ICD can be achieved with conventional cytotoxic agents, it represents a potential approach for the immunotherapy of cancer. Here, different aspects of ICD in cancer biology and treatment are reviewed.pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3067-4842pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6974-0889pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5154-7263pt_BR
dc.contributor.emailmailto:mosarcr@gmail.compt_BR
dc.contributor.emailmailto:joseavmorais@gmail.compt_BR
dc.contributor.emailmailto:rayaneganassin@hotmail.compt_BR
dc.contributor.emailmailto:giulia_rosa12@hotmail.compt_BR
dc.contributor.emailmailto:fchagas16@gmail.compt_BR
dc.contributor.emailmailto:amandaalencarcabral@gmail.compt_BR
dc.contributor.emailmailto:pandolfo.ariane@gmail.compt_BR
dc.contributor.emailmailto:victor@spctm.compt_BR
dc.contributor.emailmailto:jplongo82@gmail.compt_BR
dc.contributor.emailmailto:luisalex@unb.brpt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.